Ken Inada

1.6k total citations
78 papers, 763 citations indexed

About

Ken Inada is a scholar working on Psychiatry and Mental health, Cellular and Molecular Neuroscience and Experimental and Cognitive Psychology. According to data from OpenAlex, Ken Inada has authored 78 papers receiving a total of 763 indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Psychiatry and Mental health, 19 papers in Cellular and Molecular Neuroscience and 19 papers in Experimental and Cognitive Psychology. Recurrent topics in Ken Inada's work include Schizophrenia research and treatment (27 papers), Sleep and related disorders (16 papers) and Neuroscience and Neuropharmacology Research (14 papers). Ken Inada is often cited by papers focused on Schizophrenia research and treatment (27 papers), Sleep and related disorders (16 papers) and Neuroscience and Neuropharmacology Research (14 papers). Ken Inada collaborates with scholars based in Japan, United States and Australia. Ken Inada's co-authors include Jun Ishigooka, Kazuo Mishima, Katsuji Nishimura, Beverly H. Koller, Makoto Saji, Sheryl S. Moy, Gary E. Duncan, Kentaro Matsui, Yuki Matsui and Nakao Iwata and has published in prestigious journals such as SHILAP Revista de lepidopterología, Brain Research and Psychological Medicine.

In The Last Decade

Ken Inada

71 papers receiving 752 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ken Inada Japan 17 262 172 128 124 118 78 763
Anna Walter Switzerland 18 304 1.2× 154 0.9× 364 2.8× 60 0.5× 75 0.6× 24 889
C. Wurthmann Germany 11 311 1.2× 172 1.0× 196 1.5× 121 1.0× 63 0.5× 27 733
Tetsufumi Kanazawa Japan 15 195 0.7× 124 0.7× 218 1.7× 59 0.5× 54 0.5× 53 699
Philip Heiser Germany 19 476 1.8× 109 0.6× 191 1.5× 83 0.7× 77 0.7× 42 886
Myung A. Lee United States 15 303 1.2× 205 1.2× 64 0.5× 56 0.5× 161 1.4× 22 801
Dan Rujescu Germany 13 417 1.6× 85 0.5× 166 1.3× 60 0.5× 52 0.4× 18 919
HJ Möller Germany 15 357 1.4× 271 1.6× 165 1.3× 55 0.4× 108 0.9× 29 992
Kristina Annerbrink Sweden 14 147 0.6× 96 0.6× 227 1.8× 67 0.5× 160 1.4× 22 664
Matej Markota United States 11 172 0.7× 201 1.2× 113 0.9× 35 0.3× 64 0.5× 25 685
Anna Schuhmacher Germany 18 161 0.6× 215 1.3× 192 1.5× 41 0.3× 45 0.4× 26 731

Countries citing papers authored by Ken Inada

Since Specialization
Citations

This map shows the geographic impact of Ken Inada's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ken Inada with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ken Inada more than expected).

Fields of papers citing papers by Ken Inada

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ken Inada. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ken Inada. The network helps show where Ken Inada may publish in the future.

Co-authorship network of co-authors of Ken Inada

This figure shows the co-authorship network connecting the top 25 collaborators of Ken Inada. A scholar is included among the top collaborators of Ken Inada based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ken Inada. Ken Inada is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kimura, Tomohiko, et al.. (2024). Asenapine versus olanzapine for the treatment of nausea and vomiting in patients with cancer: A retrospective study. Neuropsychopharmacology Reports. 44(1). 158–164. 1 indexed citations
2.
Tsutsumi, Takahiro, et al.. (2024). Effect of intermittent subchronic MK‐801 administration on dopamine synthesis capacity and responsiveness in the prefrontal cortex. Neuropsychopharmacology Reports. 44(2). 333–341. 1 indexed citations
3.
Muraoka, Hiroyuki, et al.. (2024). Effects of chronic haloperidol treatment on the expression of fear memory and fear memory extinction in the cued fear‐conditioned rats. Neuropsychopharmacology Reports. 44(1). 197–205. 1 indexed citations
4.
Okada, Yusuke, Ken Inada, & Manabu Akazawa. (2023). Comparative effectiveness of long-acting injectable antipsychotics in patients with schizophrenia in Japan. Schizophrenia Research. 252. 300–308. 2 indexed citations
5.
Sakurai, Hitoshi, Ken Inada, Yumi Aoki, et al.. (2023). Management of unspecified anxiety disorder: Expert consensus. Neuropsychopharmacology Reports. 43(2). 188–194. 3 indexed citations
6.
Aoki, Yumi, Yoshikazu Takaesu, Kentaro Matsui, et al.. (2023). Development and acceptability testing of a decision aid for considering whether to reduce antipsychotics in individuals with stable schizophrenia. Neuropsychopharmacology Reports. 43(3). 391–402. 1 indexed citations
7.
Yamauchi, Shigeru, et al.. (2021). Safety profile of clozapine: Analysis using national registry data in Japan. Journal of Psychiatric Research. 141. 116–123. 5 indexed citations
8.
Yamauchi, Shigeru, et al.. (2021). A descriptive study of 10-year clozapine use from the nationwide database in Japan. Psychiatry Research. 297. 113764–113764. 9 indexed citations
9.
Ishigooka, Jun, et al.. (2021). Safety of switching to brexpiprazole in Japanese patients with schizophrenia: A post‐hoc analysis of a long‐term open‐label study. Human Psychopharmacology Clinical and Experimental. 36(4). e2777–e2777. 9 indexed citations
10.
11.
12.
Inoue, Yuichi, Mina Kobayashi, Isa Okajima, et al.. (2021). Development and validation of the Benzodiazepine Hypnotics Withdrawal Symptom Scale (BHWSS) based on item response theory. Psychiatry Research. 300. 113900–113900. 3 indexed citations
13.
Inada, Ken, et al.. (2020). Effect of residual insomnia and use of hypnotics on relapse of depression: a retrospective cohort study using a health insurance claims database. Journal of Affective Disorders. 281. 539–546. 10 indexed citations
14.
Inada, Ken. (2019). Guideline for Pharmacological Therapy of Schizophrenia 2020. 6 indexed citations
15.
Matsui, Kentaro, Yoshiteru Takekita, Ken Inada, et al.. (2019). Switching to antipsychotic monotherapy vs. staying on antipsychotic polypharmacy in schizophrenia: A systematic review and meta-analysis. Schizophrenia Research. 209. 50–57. 26 indexed citations
16.
Kishi, Taro, Ken Inada, Yuki Matsui, & Nakao Iwata. (2017). Z-drug for schizophrenia: A systematic review and meta-analysis. Psychiatry Research. 256. 365–370. 10 indexed citations
17.
Muraoka, Hiroyuki, et al.. (2016). Dopamine dynamics during emotional cognitive processing: Implications of the specific actions of clozapine compared with haloperidol. European Journal of Pharmacology. 781. 148–156. 13 indexed citations
18.
Tokuda, Michifumi, Toshiyuki Yamane, Seiichiro Matsuo, et al.. (2010). Relationship between renal function and the risk of recurrent atrial fibrillation following catheter ablation. Heart. 97(2). 137–142. 30 indexed citations
19.
Suzuki, Eiji, et al.. (2005). Effects of Intraperitoneal Administration of IFN-α for One, Four, and Fourteen Days on Amino Acid Levels in Various Rat Brain Regions. Journal of Interferon & Cytokine Research. 25(4). 187–191. 5 indexed citations
20.
Suzuki, Eiji, et al.. (2005). Effects of intraperitoneally injected lithium, imipramine and diazepam on nitrate levels in rat amygdala. Psychiatry and Clinical Neurosciences. 59(3). 358–361. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Anna Walter Breakdown of academic impact, for papers by C. Wurthmann Breakdown of academic impact, for papers by Tetsufumi Kanazawa Breakdown of academic impact, for papers by Philip Heiser Breakdown of academic impact, for papers by Myung A. Lee Breakdown of academic impact, for papers by Dan Rujescu Breakdown of academic impact, for papers by HJ Möller Breakdown of academic impact, for papers by Kristina Annerbrink Breakdown of academic impact, for papers by Matej Markota Breakdown of academic impact, for papers by Anna Schuhmacher
Rankless by CCL
2026